Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway
2005 ◽
Vol 118
(8)
◽
pp. 1892-1900
◽
2014 ◽
Vol 134
(2)
◽
pp. 372-378
◽
2010 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 23
(1)
◽
pp. 13-20
◽
Keyword(s):